Who founded Ampriondx?

Ampriondx was founded by Russell Lebovitz, Claudio Soto in 2007.

Who are Ampriondx's investors?

Ampriondx's investors include Snatched Ventures.

How much funding has Ampriondx raised?

Ampriondx has disclosed $16.7M raised across 2 rounds.

Where is Ampriondx headquartered?

Ampriondx is headquartered in San Francisco, US.

Ampriondx

San Francisco, US · Founded 2007 · Delaware corporation · 37 employees on LinkedIn · 1 known investors

Find your way into Ampriondx

32 people in our graph share verified history with the Ampriondx team — schools, employers, funds. One of them is your warm intro.

Magnus Bergmanunlockedknows Russ Lebovitz · together at BootstrapLabs (overlapped)

×6knows the team · via BootstrapLabs

×5knows the team · via Washington University School of Medicine in St. Louis

Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.

Biotech Digital Health Medical Devices

Founders & leadership

Ampriondx was founded in 2007 by Russell Lebovitz and Claudio Soto.

Russell Lebovitz inCo-founder · CEORussell Lebovitz is CEO and stockholder of Ampriondx, which develops diagnostic tests for neurodegenerative diseases including Parkinson's and Lewy body dementia. He has expertise in biotech product development, commercialization, and intellectual property.

Claudio SotoCo-founder

Peter ClintonNamed on SEC filing

Board

Marc ChanDirector & Stockholder

Rahul BhansaliBoard director

Kenneth LehmanDirector & Stockholder

Investors · 1

Snatched VenturesSan Francisco

Reported raises · per SEC filings

Form D private placements

$16.7M disclosed across 2 rounds · 2022–2024

▶$5.8MraisedSep 2024 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Marc ChanDirector
Russell LebovitzExecutive Officer, Director
Rahul BhansaliDirector

Offering amount: $15M
Amount sold: $5.8M
Proceeds to insiders: $291.5K
First sale: Sep 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11MraisedJul 2022 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Claudio SotoDirector
Marc ChanDirector
Peter ClintonDirector
Kenneth LehmanDirector
Russell LebovitzExecutive Officer, Director

Offering amount: $11M
Amount sold: $11M
Proceeds to insiders: $550K
First sale: Jun 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

CND Life Sciences9 shared keywordsCND Life Sciences develops skin-based neurodiagnostic tests, including a test to detect abnormal alpha-synuclein in skin biopsies to help physicians diagnose Parkinson's disease and related synucleinopathies. It operates a CLIA-certified and CAP-accredited pathology lab serving clinicians and patients.

Medscape8 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Ampriondx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ampriondx do?: Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.
Who founded Ampriondx?: Ampriondx was founded by Russell Lebovitz, Claudio Soto in 2007.
Who are Ampriondx's investors?: Ampriondx's investors include Snatched Ventures.
How much funding has Ampriondx raised?: Ampriondx has disclosed $16.7M raised across 2 rounds.
Where is Ampriondx headquartered?: Ampriondx is headquartered in San Francisco, US.